mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0003 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
0.18 |
0.0007 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |
mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0007 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0009 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |